Passar para o conteúdo principal
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
PT
FR
EN
PT
NL
NB
DE
IT
Início
Company Press Releases
Company press releases
Subscribe
Filtros
Filtros
Atualizar
Reiniciar
Icon After
Data
Alternar Visibilidade
All
Hoje
Esta semana
This month
Custom date range
From
To
Topic
Alternar Visibilidade
Acquisition or disposal of the issuer’s own shares
Additional regulated information required to be disclosed under the laws of a Member State
Adjustment of interest rate
Alliances and agreements
Annual financial and audit Reports
Change in Capital
Changes in the rights attaching to the classes of shares or securities
Commercial operations
Commercial results
Corporate life
Dividend
Ex Date
General meeting / Board Meeting
Half yearly financial reports and audit reports/limited reviews
Home Member State
Income
Inside information
Joint venture
Journal / appointments
Legal
Major shareholding notifications
Mandatory notification of trade primary insiders
Meetings / events
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Non-regulatory press releases
Other financial transaction
Other subject
Payments to governments
Polls / Surveys
Products and services
Prospectus / admission document
Rating
Sales
Share history
Share introduction and issues
Takeover bids
Total number of voting rights and capital
Trends / Analyses
Provider
Alternar Visibilidade
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Displaying 151 - 184 of 184 results
Released
Company
Title
Industry
Topic
04 Oct 2021
22:01 CEST
GALAPAGOS
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
20103010 Biotechnology
Other subject
04 Oct 2021
22:01 CEST
GALAPAGOS
Galapagos presenteert nieuwe data van het SELECTION fase 3-programma op het 2021 congres van de United European Gastroenterology Week (UEGW)
20103010 Biotechnology
Other subject
04 Oct 2021
07:01 CEST
GALAPAGOS
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
20103010 Biotechnology
Other subject
04 Oct 2021
07:01 CEST
GALAPAGOS
Galapagos kondigt voltooiing aan van rekrutering voor DIVERSITY fase 3-studie met filgotinib bij patiënten met de ziekte van Crohn
20103010 Biotechnology
Other subject
20 Sep 2021
22:01 CEST
GALAPAGOS
Galapagos increases share capital through subscription right exercises
20103010 Biotechnology
Other subject
20 Sep 2021
22:01 CEST
GALAPAGOS
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten
20103010 Biotechnology
Other subject
17 Sep 2021
13:15 CEST
GALAPAGOS
GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
20103010 Biotechnology
Other subject
17 Sep 2021
13:15 CEST
GALAPAGOS
GALAPAGOS KONDIGT POSITIEVE CHMP OPINIE AAN VOOR JYSELECA® (FILGOTINIB) VOOR DE BEHANDELING VAN VOLWASSENEN MET MATIGE TOT ERNSTIGE ACTIEVE COLITIS ULCEROSA
20103010 Biotechnology
Other subject
30 Aug 2021
22:01 CEST
GALAPAGOS
Galapagos kondigt gepland pensioen aan van CEO
20103010 Biotechnology
Other subject
30 Aug 2021
22:01 CEST
GALAPAGOS
Galapagos announces planned retirement of CEO
20103010 Biotechnology
Other subject
05 Aug 2021
22:01 CEST
GALAPAGOS
Galapagos rapporteert financiële resultaten eerste halfjaar met geheroriënteerde pijplijn en operationele voortgang
20103010 Biotechnology
Other subject
05 Aug 2021
22:01 CEST
GALAPAGOS
Galapagos reports H1 financial results with refocused pipeline and operational progress
20103010 Biotechnology
Other subject
14 Jul 2021
22:01 CEST
GALAPAGOS
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
20103010 Biotechnology
Other subject
14 Jul 2021
22:01 CEST
GALAPAGOS
Galapagos toont vroege klinische activiteit aan met SIK2/3-remmer bij ontstekingsziekten
20103010 Biotechnology
Other subject
14 Jul 2021
22:01 CEST
GALAPAGOS
Galapagos meldt positieve resultaten met selectieve TYK2-remmer GLPG3667 in fase 1b-studie in psoriasis
20103010 Biotechnology
Other subject
14 Jul 2021
22:01 CEST
GALAPAGOS
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
20103010 Biotechnology
Other subject
10 Jul 2021
11:10 CEST
GALAPAGOS
Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in patients with Ulcerative Colitis
20103010 Biotechnology
Other subject
10 Jul 2021
11:10 CEST
GALAPAGOS
Galapagos maakt nieuwe data bekend die een snelle symptoomverbetering en aanhoudende steroïdvrije remissie met filgotinib bij patiënten met colitis ulcerosa ondersteunen
20103010 Biotechnology
Other subject
22 Jun 2021
22:01 CEST
GALAPAGOS
Galapagos announces departure of CSO Piet Wigerinck later this year
20103010 Biotechnology
Other subject
22 Jun 2021
22:01 CEST
GALAPAGOS
Galapagos kondigt vertrek van Chief Scientific Officer Piet Wigerinck aan later dit jaar
20103010 Biotechnology
Other subject
07 Jun 2021
22:01 CEST
GALAPAGOS
Galapagos increases share capital through subscription right exercises
20103010 Biotechnology
Change in Capital
07 Jun 2021
22:01 CEST
GALAPAGOS
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten
20103010 Biotechnology
Change in Capital
04 Jun 2021
07:01 CEST
GALAPAGOS
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
20103010 Biotechnology
Other subject
04 Jun 2021
07:01 CEST
GALAPAGOS
SELECTION-studie naar filgotinib bij colitis ulcerosa, gepubliceerd in The Lancet
20103010 Biotechnology
Other subject
27 May 2021
22:01 CEST
GALAPAGOS
Galapagos presenteert tijdens het congres van de European League Against Rheumatism (EULAR) gegevens over reumatoïde artritis
20103010 Biotechnology
Other subject
27 May 2021
22:01 CEST
GALAPAGOS
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
20103010 Biotechnology
Other subject
18 May 2021
22:01 CEST
GALAPAGOS
Galapagos kondigt deelname van eerste patiënt in de FILOSOPHY-studie aan voor meer inzicht in de werkzaamheid en veiligheid van Jyseleca (filgotinib) in de praktijk
20103010 Biotechnology
Other subject
18 May 2021
22:01 CEST
GALAPAGOS
Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting
20103010 Biotechnology
Other subject
06 May 2021
22:01 CEST
GALAPAGOS
Galapagos heroriënteert pijplijn en stroomlijnt organisatie
20103010 Biotechnology
Other subject
06 May 2021
22:01 CEST
GALAPAGOS
Galapagos refocuses pipeline and rightsizes operations
20103010 Biotechnology
Other subject
04 May 2021
22:01 CEST
GALAPAGOS
Transparency notification received from The Capital Group
20103010 Biotechnology
Other subject
04 May 2021
22:01 CEST
GALAPAGOS
Transparantieverklaring ontvangen van The Capital Group
20103010 Biotechnology
Other subject
30 Apr 2021
22:01 CEST
GALAPAGOS
Galapagos creates new subscription right plans
20103010 Biotechnology
Change in Capital
30 Apr 2021
22:01 CEST
GALAPAGOS
Galapagos creëert nieuwe inschrijvingsrechtenplannen
20103010 Biotechnology
Change in Capital
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Paginação
«
« First
‹
‹‹
2
3
4
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
your account
section or
create an account
.
Início
Mercados
Euronext Amesterdão
Cash Products
Stocks
AEX index Stocks
AEX ESG Stocks
Indices
Funds
Bonds
ETFs
Structured products
Derivative products
Index options
Index futures
Stock options
Dividend derivatives
Stock futures
Quote Vendor Codes
Company regulated news
Latest
Archive
Euronext Bruxelas
Cash products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indices
Bonds
ETFs
Structured Products
Derivative products
Index futures
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Expert Market
Euronext Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Euronext Lisboa
Mercados a contado
Acções
Euronext regulated
Euronext Access
PSI Stocks
Indices
Obrigações
Derivados
Futuros sobre os Índices
Futuros sobre os Acções
Dividendos Derivados
Quote Vendor Codes
Comunicados empresas
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Cash Products
Stocks
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX stocks
OBX ESG Stocks
OSEBX stocks
OSEFX Stocks
Seafood Stocks
Shipping Stocks
Equity indices
Bonds
Oslo Børs
Nordic Alternative Bond Market
Bond indices
ETFs
Funds
Derivatives
Derivative products
Quote Vendor Codes
Company regulated news
Latest
Archive
Financial calendars
Primary insiders
Paris
Cash Products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indices
Bonds
ETFs
Structured products
Derivative products
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Acções
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Company regulated news
Latest
Archive
IPOs
All IPOs
Listing sponsors
Euronext Tech Leaders
Family business
Indices
Directory
ESG indices
Indices documents
Indices news
Index consultations
Contact Euronext indices
ETFs
Directory
ESG ETFs
Fundos
Directory
ESG Funds
Oslo Mutual Funds
Obrigações
ESG Bonds
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Warrants & Certificados
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Acções/Câmbio Derivados
Index Futures
Index Options
Stock Options
Stock Futures
Dividend Derivatives
ETF Options
Contracts specifications
Tick Sizes
Wholesale Trading
Quote vendor codes
Matérias-Primas
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Trading calendars
Delivery
Wholesale Trading
Commitments of Traders (CoT) report
Contracts specifications
Quote vendor codes
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Recursos
Statistics & reports
Quality of execution
Trading hours & Holidays
Contract specifications
Quote vendor codes
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Market events
Suspended instruments
Stressed Market Conditions
Breach of Double Cap limits
Exceptional Market Conditions
Miscellaneous short messages
Market status
Members list
Issuers compliance
Onde encontrar